Organoids: Current Applications and Future Directions
ABSTRACT Organoids are three‐dimensional multicellular structures derived from stem cells or primary tissues that recapitulate key structural and functional features of native organs. Advances in stem cell biology, biomaterials, and bioengineering have established organoids as powerful platforms for studying human development and disease mechanisms, drug discovery, precision medicine, and regenerative medicine. However, current organoid models are limited by incomplete maturation, insufficient vascularization, inadequate immune and neural integration, and poor reproducibility, restricting their physiological relevance and clinical translation. Moreover, the rapid expansion of organoid research has created a need for an updated synthesis of the technological advances, biological applications, and remaining challenges. This review provides a comprehensive overview of organoid technology, covering strategies for organoid generation, including cell sources, three‐dimensional culture systems, extracellular matrix support, and microenvironment engineering, followed by representative applications of brain, retinal, kidney, cardiac, lung, liver, intestinal, and endometrial organoids. We further discuss current technical bottlenecks and highlight emerging solutions, including organ‐on‐chip platforms, multiorgan integration, multiomics, clustered regularly interspaced short palindromic repeats(CRISPR)‐based engineering, artificial intelligence, standardized biobanks, and clinical translation. By integrating recent advances across diverse organoid systems, this review provides a framework for developing more physiologically relevant and clinically translatable organoid models.
Authors
- Rong Li (ORCID: https://orcid.org/0000-0003-0305-5579)
- Yang Yu (ORCID: https://orcid.org/0000-0001-7283-9663)
- Ping Zhou (ORCID: https://orcid.org/0000-0002-8183-7747)
- Canhui Cao (ORCID: https://orcid.org/0000-0002-7328-0264)
- Dan Mo (ORCID: https://orcid.org/0000-0003-4877-7532)
- Zhonghong Zeng
- Yueqi Leng
- Shangqi Li (ORCID: https://orcid.org/0009-0000-1702-9406)
- Heng Pan (ORCID: https://orcid.org/0000-0002-5407-5687)
- Yilei He
- Yue Wang
- Feng Deng
- Xingtong Chen
- Weisi Lian
- Mingmei Lin
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking University (CN)
- Beijing Hospital (CN)
- Wuhan Union Hospital (CN)
- Peking University Third Hospital (CN)
- National Center for Clinical Laboratories (CN)
- China National Research Institute of Food and Fermentation (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- MedComm
- Published
- 2026-09-30
- DOI
- https://doi.org/10.1002/mco2.70965
- Primary Topic
- Pluripotent Stem Cells Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00